Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 10,200 shares at $30.07 ($307K) on 2016-11-10, disclosed to the SEC on 2016-11-14.
Open-market sale of $307k ACAD by EVP AND GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |
| ACAD | SELL | 2017-07-21 | $1.1M | — | Filing → |